Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differences in the autoantibody phenotypes and long-term outcomes between juvenile- and adult-idiopathic inflammatory myopathies.

Seminars in arthritis and rheumatism - 1 Oct 2024

Tsuji Hideaki, Nakashima Ran, Yasumi Takahiro, Sasai Tsuneo, Ichimura Yuki, Shirakashi Mirei, Onizawa Hideo, Hiwa Ryosuke, Kitagori Koji, Akizuki Shuji, Onishi Akira, Yoshifuji Hajime, Tanaka Masao, Okiyama Naoko, Mimori Tsuneyo, Morinobu Akio

Abstract excerpt

OBJECTIVE: To investigate differences in autoantibodies, clinical features, and long-term outcomes between juvenile-idiopathic inflammatory myopathy (IIM) and adult-IIM METHODS: Autoantibodies, clinical characteristics, and drug-free conditions for a maximum of 20 years were retrospectively analyzed in 320 Japanese IIM patients (juvenile-IIM, n = 34; adult-IIM, n = 286) using the Kyoto University Registry....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Autoantibodies

Share to Myositis

Share to Phenotype

Share to Registries

Share to Young Adult

Source

Identifiers

PMID: 39142036
DOI: 10.1016/j.semarthrit.2024.152530

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differences in the autoantibody phenotypes and long-term outcomes between juvenile- and adult-idiopathic inflammatory myopathies.PMID 39142036Read ↗

The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.Semantic proximity Read ↗

Juvenile idiopathic inflammatory myositis: an update on pathophysiology and clinical care.Semantic proximity Read ↗

The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes.Semantic proximity Read ↗

Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations.Semantic proximity Read ↗

The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.Semantic proximity Read ↗

Spectrum of clinical phenotypes associated with myositis-specific and myositis-associated antibodies in juvenile idiopathic inflammatory myositis: Our experience from North India.Semantic proximity Read ↗

Myositis-specific autoantibodies and their clinical associations in Idiopathic Inflammatory MyopathiesSemantic proximity Read ↗

Association of NXP2 autoantibodies with a more severe clinical phenotype of juvenile dermatomyositis.Semantic proximity Read ↗

Clinical characteristics and prognostic analysis of idiopathic inflammatory myopathy with positive anti-aminoacyl-tRNA synthetase antibodiesSemantic proximity Read ↗

Anti-melanoma-associated Antigen A1 Autoantibodies Predict the Outcome of Patients With Idiopathic Inflammatory Myopathies Related Interstitial Lung DiseaseSemantic proximity Read ↗

Clinical-pathologic classification of anti-HMGCR-positive immune-mediated necrotizing myopathySemantic proximity Read ↗

Anti-nuclear matrix protein 2 antibody-positive idiopathic inflammatory myopathies represent extensive myositis without dermatomyositis-specific rashSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.